Pictet Asset Management Holding SA trimmed its holdings in shares of Xylem Inc. (NYSE:XYL - Free Report) by 17.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,355,809 shares of the industrial products company's stock after selling 1,106,911 shares during the quarter. Xylem makes up approximately 0.7% of Pictet Asset Management Holding SA's investment portfolio, making the stock its 25th biggest holding. Pictet Asset Management Holding SA owned about 2.20% of Xylem worth $621,381,000 as of its most recent SEC filing.
Other large investors also recently bought and sold shares of the company. Raymond James Trust N.A. lifted its position in shares of Xylem by 14.8% during the third quarter. Raymond James Trust N.A. now owns 2,200 shares of the industrial products company's stock valued at $297,000 after buying an additional 284 shares during the last quarter. Brown Brothers Harriman & Co. raised its stake in shares of Xylem by 12.5% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 973 shares of the industrial products company's stock worth $131,000 after acquiring an additional 108 shares in the last quarter. Brooklyn Investment Group purchased a new stake in Xylem during the third quarter valued at approximately $55,000. BNP Paribas Financial Markets boosted its stake in Xylem by 16.5% in the third quarter. BNP Paribas Financial Markets now owns 547,435 shares of the industrial products company's stock valued at $73,920,000 after acquiring an additional 77,639 shares in the last quarter. Finally, Glenmede Trust Co. NA grew its holdings in Xylem by 3.4% in the third quarter. Glenmede Trust Co. NA now owns 18,399 shares of the industrial products company's stock worth $2,484,000 after purchasing an additional 605 shares during the last quarter. Institutional investors own 87.96% of the company's stock.
Xylem Stock Performance
NYSE XYL traded up $0.37 on Tuesday, hitting $119.83. 272,725 shares of the company's stock traded hands, compared to its average volume of 1,466,773. The firm's 50-day moving average price is $125.69 and its two-hundred day moving average price is $125.77. The firm has a market capitalization of $29.12 billion, a PE ratio of 32.74, a P/E/G ratio of 2.33 and a beta of 1.08. The company has a current ratio of 1.76, a quick ratio of 1.33 and a debt-to-equity ratio of 0.19. Xylem Inc. has a 1-year low of $113.26 and a 1-year high of $146.08.
Xylem (NYSE:XYL - Get Free Report) last posted its earnings results on Tuesday, February 4th. The industrial products company reported $1.18 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.12 by $0.06. The company had revenue of $2.30 billion during the quarter, compared to the consensus estimate of $2.18 billion. Xylem had a net margin of 10.40% and a return on equity of 9.96%. The firm's quarterly revenue was up 8.6% on a year-over-year basis. During the same period in the previous year, the firm posted $0.99 earnings per share. As a group, analysts expect that Xylem Inc. will post 4.65 EPS for the current year.
Xylem Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Wednesday, March 19th. Investors of record on Tuesday, February 18th were given a dividend of $0.40 per share. This is a boost from Xylem's previous quarterly dividend of $0.36. This represents a $1.60 annualized dividend and a yield of 1.34%. The ex-dividend date was Tuesday, February 18th. Xylem's dividend payout ratio (DPR) is currently 43.72%.
Wall Street Analysts Forecast Growth
A number of analysts have recently weighed in on the company. Citigroup cut Xylem from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, February 5th. Stifel Nicolaus lowered their price target on Xylem from $166.00 to $150.00 and set a "buy" rating for the company in a report on Friday, January 24th. Robert W. Baird upped their price objective on shares of Xylem from $139.00 to $148.00 and gave the company an "outperform" rating in a report on Wednesday, February 5th. Finally, Wolfe Research reiterated a "peer perform" rating on shares of Xylem in a research note on Thursday, December 12th. Four analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $149.89.
Read Our Latest Report on Xylem
Xylem Profile
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Featured Articles

Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.